Abstract
This Best Practice review synthesizes evidence from five key clinical trials to evaluate whether dupilumab improves sinonasal outcomes in AERD patients who have undergone prior endoscopic sinus surgery.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2648-2650 |
| Number of pages | 3 |
| Journal | Laryngoscope |
| Volume | 135 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2025 |
Keywords
- adult rhinology
- allergy/rhinology
- clinical
- head and neck
- immunotherapy
- nose and paranasal sinuses
- Rhinitis/drug therapy
- Humans
- Antibodies, Monoclonal, Humanized/therapeutic use
- Treatment Outcome
- Sinusitis/drug therapy
- Endoscopy
ASJC Scopus subject areas
- Otorhinolaryngology
Fingerprint
Dive into the research topics of 'Does Dupilumab Improve Sinonasal Outcomes in AERD Patients?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS